SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (30158)1/12/2000 12:24:00 PM
From: Sleepman  Read Replies (1) | Respond to of 32384
 
Henry
I have been doing a little strolling through the literature regarding retinoids and cancer. It seems that there is both in vitro and vivo data that suggests that interferon may synergize with retinoids in cancer treatment. Any word about upcoming studies with targretin in this regard? Specifically there was info in vitro on breast, and in vivo with pancreas. They were using older retinoids, so I wonder what that means for Ligand. Just some thoughts. Dan



To: Henry Niman who wrote (30158)1/12/2000 12:40:00 PM
From: Mudcat  Respond to of 32384
 
Hank, I notice that you failed to mention Panretin in your update. Nothing reported on Panretin from the H&Q conference either. Are they still trying to sell initial inventories? Has Lgnd written Panretin off as a flop?



To: Henry Niman who wrote (30158)1/13/2000 9:16:00 AM
From: Joseph Chuan  Respond to of 32384
 
Thanks for the prompt response. I will be looking for more news on this company.

Thanks,

Joe


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News